enVVeno Medical Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
33
- Stock Symbol
-
NVNO
- Share Price
-
$6.22
- (As of Monday Closing)
enVVeno Medical General Information
Description
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Contact Information
Website
www.envveno.comCorporate Office
- 70 Doppler
- Irvine, CA 92618
- United States
Corporate Office
- 70 Doppler
- Irvine, CA 92618
- United States
enVVeno Medical Stock Performance
As of 16-Nov-2026, enVVeno Medical’s stock price is $6.22. Its current market cap is $4.13M with 695K shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.22 | $6.17 | $5.80 - $14.66 | $4.13M | 695K | 30.5K | -$23.35 |
enVVeno Medical Financials Summary
As of 30-Sep-2026, enVVeno Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (15,561) | (23,676) | 5,728 | 44,229 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (15,322) | (19,675) | (21,680) | (23,150) |
| Net Income | (15,552) | (19,472) | (21,819) | (23,516) |
| Total Assets | 19,489 | 29,562 | 44,954 | 48,635 |
| Total Debt | 408 | 700 | 1,064 | 1,402 |
enVVeno Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
enVVeno Medical Comparisons
Industry
Financing
Details
enVVeno Medical Competitors (21)
One of enVVeno Medical’s 21 competitors is Endologix, a Corporation company based in Santa Rosa, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Endologix | Corporation | Santa Rosa, CA | ||||
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Electromed | Corporation | New Prague, MN | ||||
| Dornier MedTech | Corporation | Weßling, Germany | ||||
| Medtronic | Corporation | Minneapolis, MN |
enVVeno Medical Patents
enVVeno Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023220249-A1 | Method of manufacturing a valve for transcatheter delivery | Inactive | 11-May-2022 | ||
| US-20230363901-A1 | Transcatheter valve for venous insufficiency | Pending | 11-May-2022 | ||
| WO-2023220254-A1 | Transcatheter valve for venous insufficiency | Inactive | 11-May-2022 | ||
| AU-2023268468-A1 | Transcatheter valve system and method for venous insufficiency | Pending | 11-May-2022 | ||
| EP-4522079-A1 | Transcatheter valve system and method for venous insufficiency | Pending | 11-May-2022 | A61F2/2475 |
enVVeno Medical Signals
enVVeno Medical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
34.52 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
enVVeno Medical FAQs
-
When was enVVeno Medical founded?
enVVeno Medical was founded in 1999.
-
Where is enVVeno Medical headquartered?
enVVeno Medical is headquartered in Irvine, CA.
-
What is the size of enVVeno Medical?
enVVeno Medical has 33 total employees.
-
What industry is enVVeno Medical in?
enVVeno Medical’s primary industry is Therapeutic Devices.
-
Is enVVeno Medical a private or public company?
enVVeno Medical is a Public company.
-
What is enVVeno Medical’s stock symbol?
The ticker symbol for enVVeno Medical is NVNO.
-
What is the current stock price of enVVeno Medical?
As of 16-Nov-2026 the stock price of enVVeno Medical is $6.22.
-
What is the current market cap of enVVeno Medical?
The current market capitalization of enVVeno Medical is $4.13M.
-
Who are enVVeno Medical’s competitors?
Endologix, Merit Medical Systems, Electromed, Dornier MedTech, and Medtronic are some of the 21 competitors of enVVeno Medical.
-
What is enVVeno Medical’s annual earnings per share (EPS)?
enVVeno Medical’s EPS for 12 months was -$23.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process